UBS Upgrades AstraZeneca (AZN) to Buy; Shares on the Move
Tweet
Share
E-mailGet Alerts AZN Hot Sheet
Price: $92.77 --0%
Rating Summary:
19 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
19 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
AstraZeneca (NYSE: AZN) shares have been volatile over the last half-hour of trading as we are hearing UBS upgraded the stock from Neutral to Buy in an intraday research report.
The stock is now up 0.8 percent to $51.78; about 20 minutes ago, AZN shares had been trading as low as $51.60.
For more ratings news on AstraZeneca click here and for the rating history of AstraZeneca click here.
The stock is now up 0.8 percent to $51.78; about 20 minutes ago, AZN shares had been trading as low as $51.60.
For more ratings news on AstraZeneca click here and for the rating history of AstraZeneca click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated statistically significant and clinically meaningful improvement in PFS as 1st-line treatment of patients with HER2-mutant advanced non-small ce
- Freedom Broker Upgrades Taylor Devices, Inc. (TAYD) to Buy
- BofA Securities Upgrades Etsy (ETSY) to Buy, 'Still Room to Run'
Create E-mail Alert Related Categories
UpgradesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
